Pfizer SWOT Analysis
Pfizer SWOT Analysis
Jennifer Yacovazzi
MGT/521
July 15, 2013
Robert Balcerzak
Pfizer SWOT Analysis
“Pfizer is the world’s largest biopharmaceutical company. It portfolio includes human biological, small molecular medicine, vaccines and consumer products” (Market Line, 2013, p. 3). “Pfizer conducts business through five different areas: primary care, established products within the emerging markets, specialty care with oncology, animal health, and consumer health care” (Market Line, 2013, p. 4). Pfizer’s founded by Charles Pfizer and Charles Erhart in 1849. Pfizer’s mass production of penicillin boosted the company and lead to its initial public offerings in 1942. Pfizer’s mission: “We will become the world’s most valued company to patients, customers, colleagues, investors, business partners, and the communities where we work and live” (Pfizer, 2013).
In viewing the results of the SWOT analysis Pfizer is a marketing partner of choice for medium and small pharmaceutical companies to commercialize their products (Market Line, 2013, p. 25). Health care cost containment pressures could affect the company’s top-line growth (Market Line, 2013, p. 25). Strengths in Pfizer’s favor are big ticket deals with M&A to sustain the leadership position, acquiring King Pharmaceuticals, and developing stronger commercials. Developing these strengths help give Pfizer the leading edge on the market for biopharmaceuticals, pain management, and developing commercials give the driving force for sales growth for new or already launched products.
Some weaknesses Pfizer will have to improve on are a heavy reliance on Lipitor and explosive growth to generic erosion (Market Line, 2013, p. 26). Pfizer dominated the globe with sales of the medication Lipitor, however; by the mid-2006 a generic impact has slowed sales. “With patent expiry Lipitor is exposed to generic competition, which could have a significant impact on the overall performance of the company”
Jennifer Yacovazzi
MGT/521
July 15, 2013
Robert Balcerzak
Pfizer SWOT Analysis
“Pfizer is the world’s largest biopharmaceutical company. It portfolio includes human biological, small molecular medicine, vaccines and consumer products” (Market Line, 2013, p. 3). “Pfizer conducts business through five different areas: primary care, established products within the emerging markets, specialty care with oncology, animal health, and consumer health care” (Market Line, 2013, p. 4). Pfizer’s founded by Charles Pfizer and Charles Erhart in 1849. Pfizer’s mass production of penicillin boosted the company and lead to its initial public offerings in 1942. Pfizer’s mission: “We will become the world’s most valued company to patients, customers, colleagues, investors, business partners, and the communities where we work and live” (Pfizer, 2013).
In viewing the results of the SWOT analysis Pfizer is a marketing partner of choice for medium and small pharmaceutical companies to commercialize their products (Market Line, 2013, p. 25). Health care cost containment pressures could affect the company’s top-line growth (Market Line, 2013, p. 25). Strengths in Pfizer’s favor are big ticket deals with M&A to sustain the leadership position, acquiring King Pharmaceuticals, and developing stronger commercials. Developing these strengths help give Pfizer the leading edge on the market for biopharmaceuticals, pain management, and developing commercials give the driving force for sales growth for new or already launched products.
Some weaknesses Pfizer will have to improve on are a heavy reliance on Lipitor and explosive growth to generic erosion (Market Line, 2013, p. 26). Pfizer dominated the globe with sales of the medication Lipitor, however; by the mid-2006 a generic impact has slowed sales. “With patent expiry Lipitor is exposed to generic competition, which could have a significant impact on the overall performance of the company”
Cited: Market Line. (June 26, 2013). Company Profile Pfizer Inc. Retrieved from http://marketline.com. Pfizer. (2013). About Pfizer. Retrieved from http://www.pfizer.com.